Evommune (EVMN) Change in Acquisitions & Divestments (2024 - 2026)

Evommune (EVMN) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $23.5 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $23.5 million, up 74.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.1 million (changed N/A YoY), and the FY2025 annual result was $84.1 million, down 2.61% from the prior year.
• Change in Acquisitions & Divestments eased to $23.5 million in Q1 2026 per EVMN's latest filing, from $37.6 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $37.6 million in Q4 2025 and troughed at $11.5 million in Q4 2024.
• A 3-year average of $21.5 million and a median of $18.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments jumped 226.96% in 2025, then surged 74.07% in 2026.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $11.5 million in 2024, then jumped by 226.96% to $37.6 million in 2025, then tumbled by 37.5% to $23.5 million in 2026.
• Business Quant data shows EVMN's Change in Acquisitions & Divestments at $23.5 million in Q1 2026, $37.6 million in Q4 2025, and $13.5 million in Q1 2025.